A study on atherogenic indices of pregnancy induced hypertension patients as compared to normal pregnant women

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 7, 2015, Pages BC05-BC08

  Singh, Meenakshi ^a   Pathak, Mauchumi Saikia ^b   Paul, Anindita ^c  

^a Bhagwan Mahaveer Cancer Hospital and Research Centre   (India)

^b GAUHATI MEDICAL COLLEGE   (India)

^c Vidal health TPA   (India)

Author keywords

Atherogenic coefficient; Atherogenic index of plasma; Cardiac coefficient; Lipid profile; Pre eclampsia

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROGENIC COEFFICIENT; ATHEROGENIC INDEX OF PLASMA; BLOOD PRESSURE MEASUREMENT; CARDIAC RISK RATIO; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; HUMAN; LIPID ANALYSIS; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANT WOMAN; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT;

EID: 84937565251     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/13505.6241     Document Type: Article

References (35)

1. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Catherine YS. Chapter: Hypertensive disorders in pregnancy. Williams Obstetrics. 23rd ed. New York: Mc Graw Hill Companies; 2010. pp. 706-56.
2. Pre-eclampsia and maternal mortality: global burden. [Online]. 2013; Available from:URL:http://www.pre-eclampsia.org/health-information/149-advocacy-awareness/332-pre-eclampsia-and-maternal-mortality-a-global-burden.
3. Dutta DC. Chapter: Hypertensive disorders in pregnancy. Textbook of Obstetrics. 7th ed. Kolkata: New Central Book Agency; 2011. Pp. 219-40.
4. Negre-salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R. Pathological aspects of lipid peroxidation. Free Radical Research. 2010;44(10):1125-71.
5. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of pre-eclampsia:an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286:H1389-93.
6. Lampinen KH, Ronnback M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens. 2006 Apr;24(4):751-756.
7. Ramsay JE, Stewart F, Greer IA, et al. Microvascular dysfunction: a link between preeclampsia and maternal coronary heart disease. BJOG. 2003;110:1029-31.
8. De J, Mukhopadhyay AK, Saha PK. Study of serum lipid profile in pregnancy induced hypertension. Indian Journal of Clinical Biochemistry. 2006;21(2):165-68.
9. Millan J, Pinto X, Munoz A, Zuniga M, Rubies-Prat J, Pallardo LF. Lipoprotein ratios: Physiological Significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management. 2009;5:757-65.
10. Bafna A, Maheshwari RS, Ved RK, Sarkar PD, Batham AR. Study of Atherogenic Indices In Nephrotic Syndrome. Int J Biol Med Res. 2012;3(3):2257-60.
11. Dobiasova M, Frohlich J, Sedova M, Cheung MC, Brown BG. Cholesterol Esterification and Atherogenic Index of Plasma correlate with Lipoprotein size and findings on Coronary Angiography. J Lipid Res. 2011;52(3):566-71.
12. Deric M, Kojic-Damjanov S, Cabarkapa V, Eremic N. Biochemical Markers of Atherosclerosis. JMB. 2008;27(2):148-53.
13. Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J, et al, editors. Chapter: The pathogenesis, prevention and treatment of atherosclerosis. Harrison’s principles of internal medicine. 17th ed. New York: McGraw-Hill; 2008. pp. 1501-09.
14. Dobiasova M. Czech. Calculator of atherogenic risk. [Online] Available from: URL:http://www.biomed.cas.cz/fgu/aip/ calculator.php
15. Sahu S, Abraham R, Vedavalli R, Daniel M. Study of lipid profile,lipid peroxidation and vitamin E in pregnancy induced hypertension. Indian J Physiol Pharmacol. 2009;53(4):365-69.
16. Cekmen MB, Erbagci AB, Duman C, Maral H, Ergen K, Ozden M, et al. Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension. Clinical Biochemistry. 2003;36:575-78.
17. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index:correlation with lipoprotein particle size and esterification rate in apo B-lipoprotein-depleted plasma (FERHDL). Clinical Biochemistry. 2001; 34:583-88.
18. Nwagha UI, Ikekpeazu EJ, Ejezie FE, Neboh EE, Maduka IC. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. African Health Sciences. 2010;10(3):248-52.
19. Pushparaj JL, Subramanyam G. Dyslipidemia in preeclampsia-risk factor for future maternal cardiovascular diseases. Journal of Evolution of Medical and Dental Sciences. 2012;1(4):487-95.
20. Begum Z, Ara I, Shah ABS. Association between lipid profile and pre-eclampsia. Ibrahim Card Med J. 2011;1(1):41-44.
21. Third report of the National Cholesterol Education Program (NCEP) expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. National Cholesterol Education Program. [online] 2002 Sep. Available from: URL: http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf
22. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis 2007. BMJ. 2007;335:974-77.
23. Grossman E. Does Increased Oxidative Stress Cause Hypertension? Diabetes Care. 2008;31(Suppl. 2):S185-89.
24. Diderholm B, Stridsberg M, Ewald E, Lindeberg-Norden S, Gustafsson J. Increased lipolysis in non-obese pregnant women studied in the third trimester. BJOG: an International Journal of Obstetrics and Gynaecology. 2005;112:713-18.
25. Adiga U, D’Souza V, Kamath A, Mangalore N. Antioxidant activity and lipid peroxidation in pre-eclampsia. J Chin Med Assoc. 2007;70(10):435-38.
26. Bharadwaj R, Mathur K, Sharma D, Sankhla M. The Relationship between Oxidative Stress and Atherogenic Index (A.I.) in Pre-eclampsia. Sch J App Med Sci. 2014;2(6D):3092-96.
27. Kashinakunti SV, Sunitha H, Gurupadappa K, Manjula R. Lipid Profile In Preeclampsia - A Case Control Study. Journal of Clinical and Diagnostic Research. 2010;(4):2748-51.
28. Bennal A, Kammar KF. Role of Triglycerides -In Severity of Pre-Eclampsia. J Phys Pharm Adv. 2012;2(11):360-64.
29. Adewolu OF, Alaje A. Study of serum lipid profile in pregnancy induced hypertension in Benin city. AJOL. 2013;12(1):1-7. Available from: URL: http://www. ajol.info /index.php/abs/article /view/87617.
30. Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Smith GD, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia:population based cohort study. BMJ. 2007; 335: 978.
31. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005: 330:565.
32. Barden A, Ritchie J, Walters B, Michael C, Rivera J, Mori T, et al. Study of Plasma Factors Associated With Neutrophil Activation and Lipid Peroxidation in preeclampsia. Hypertension. 2001;38:803-08.
33. Madejczyk M, Kruszynski G, Breborowicz GH. aetiopathology of pre-eclampsia. Archives of Perinatal Medicine. 2009;5(3):144-51.
34. Sharma M, Gnaguly NK. Premature coronary artery disease in Indians and its associated risk factors. Vascular Health and Risk Management. 2005;1(3):217-25.
35. Pandey S, Srinivas M, Agashe S, Joshi J, Galvankar P, Prakasam CP, et al. Menopause and metabolic syndrome: A study of 498 urban women from western India. Journal of Mid-life Health. 2010;1(2):63-69.